Charlty registration number 1132901 (England and Wales Company reg15tration number 06230101 HOMEOPATHY RESEARCH INSTITUTE ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Doc ID: 23ba9c743a1011a57a3dd7661ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE LEGAL AND ADMINISTRATIVE INFORMATION Trustees A L Touinier Mr C J V*lansbrough DrAHARoss MrA F T Winkler Secretary Mr B Dowdeswell Charity number IEngland and Wale8> 1132901 Company number I230101 Registered offl¢e Internalional House 142 Cromwell Road Kensinglon London Sv1 4EF Audltor Mander Duffill The Old Post Office 41-43 Market Place Chippenham Wlllshire SN15 3HR Doc10'. 23ba9c743a1011a57a3dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE CONTENTS Page Twslees, report Slalemenl of trustees, responsibilities Independent auditor's feport Stalem8nt of ffinancial activities 10 8alance sheel 11 Slatemenl of cash Ilows 12 Notes lo the accounts 13-26 Do¢ ID.. 23ba9¢74381011a57a3dd7681a¢7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE TRUSTEES. REPORT {INCLUDING DIRECTORS. REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 The trustees present their reporl and fnan¢ial slalements for the year ended 31 Oecember 2024. The accounts have been prepared in accordanc8 With the accounling policies set out in note 1 to the accounls and Comply wilh the charily's governing documenl. the Companies Ad 2006 and "Accounling and Reporting by Charities: Statement of Recommended Practice applicable lo charities preparing their a¢counls in accordance wilh the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). (as amended for accounting periods commencing from 1 January 2016) Our alms and obJectlve8 oses and ain)s The Homeopathy Research Instilule (HRI) is a UK-based charity dedicaled to prornoting high-quality sclenllfic research in homeopalhy al an internalional level. The Inslilule used ils resources and expertise lo foster néw projecls. improve Ihe qualily of research being carried out in Ihe field and communicate the existlng evidence on homeopalhy to new audiences. There has been no change in these objectives during Ihe year. Ensurin our woTk delivers our ai The trustees have paid due regard to guidance issued by the Charity Commission in deciding what aclivilies the chafily should undertake. The Homeopathy Research Institute (HRI) team engaged in a typically diverse range of acllvilies In 2024, all of which conlribuled effectively to eilher generaling new high quality research in homeopalhy or communicating lh& evidence base. As such, all actlvilles fulfilled HRI'S slialegic aims and objectives. HRI'S biennial inlernalional homeopalhy researd) conferences - recognised as the leading evenl of Ih8ir kind worldwide provide a professional plalform for researchers lo present Iheir findings and a unique forum for inleinalional collaboration. Preparalions for Ihe 6th HRI International Research Conference 'HRI Gr8ec8 2025, progressed on schedule, with widespread positive feedback following announ¢emenl of the location in Thessaloniki and our emlnenl keynote speakers. Six active HRI research projects progiessed in 2024. with one reaching complelion (olills media revlew) and one new PfO3ecl being launched (Crealing a core outcome sel for acule otilis media). Two scienlific publications were generated the acute olilis media systematic rewew related lo antimicrobial resistance (Perry et al. H81ion, 2024) and a third paper from the ongoing Clificol data collection project {Toumiei el al. OBM Inlegratlve and Complemenlary medIne, 2024). On requesl, HRI responded Io fequesls for information andlor provided academic input to multip18 8xlemal projects throughout the year. This activity took various forms. including pro bono advice to support academic5 involved in homeopathy research for other organisalions and acceptir)g invitations lo peer review articles submitted lo journals for publl¢alion. Ooc ID: 23ba9c743a1011a57a3dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE TRUSTEES, REPORT {CONTINUED)(INCLUDING DIRECTORS, REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 The HRI'S academic team disseminaled the findings of high-quality research in homeopalhy at an unprecedenled level by accepting invitations lo deliver 22 presenlalions at external events in 12 counlries, including conferences. webinars and expert meetings <2023: 15 evenls in 6 counlfies). The HRI website - available in three languages (English, French and German) conlinues Io feach an ever- growing audience. and is recognised as Ihe leading websile on homeopalhy research worldwide. HRI'S Homeopathy FAQS presenled in 12 languages - continues to be the mosl well-used HRI communications re$our¢e. The scientific contenl of the FAQS and Resources se¢lion of Ihe HRI website undeent regular updates in 2024 to r8f]ecl the lalest developments in Ihe field, providing an essential and unique resource on this topic. A key communicalions highlight for 2024 was publication of the 'HRI Evldence Summary.. providing a much- needed a¢ademi¢ally robust. yet easy lo read. single document on homeopathy research. Rellecting on anolher year of intensrve ac11¥tIeS, the Twstees noled that extensive pogllive feedback In 2024 has provided on-going cnnfirmalion Ihal the Inslilute's work is highly valued for our unlque combination of high-level academic expertise, and ability lo create eaSY-lUnderSIand materials making ihe science on this IopiG availab18 lo a wide audience, including th8 general public, patients and decision-makers alike. urac ies deliver Members of the public need aceurate and Upldate Information in order to make informed choices about healthcare options, Including homeopathy. The Trustees therefore believ8 Ih8Te is a clear benefit from a number of Ihe Instilute's aclivilles, including- Conducting and assisling wilh novel fesear¢h into homeopathic medicines and treatment Holding conferences and expert meetings lo facilitate international ¢ollal)orallon between fesearcheis and dlssemlnation of the lalesi findings In the field Communicating accurale and up-lo-dale information about homeopathy research to prof8S8ionals and the public via printed material. webslte. social media and eleclroniG newsletters. Doc10: 23ba9c743a1011a57a3dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE TRUSTEES, REPORT (CONTINUED)(INCLUDING DIRECTORS, REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 Financial review The TrLfslees are mindful ol the necessity to generate sufficienl incoming resources to furKI bolh scientific research projects and Ihe Inslitule's other activit18s. Research projecl funding commilmenls are relatively short term and the Truslees only commit lo funds currently in hand. HRI reports a surplus for the year of £1,122,354 on total expendilure of £490,511. increasing fund balances to £1.612.889. Income rose from £712,871 in 2023 to £1.612.865 in 2024. due primarily to a subslanlial one-off r8sliicled donalion and associated Gift Aid. Tolal donation income in 2024 was £1,582,145, comprising £559,213 unrestri¢led and £1.022.932 rèstricted funding. This compares lo total donations in 2023 of £577,882, of which £425,614 was unreslricled and £152,268 restricted. The increase is largely attributable lo a significant reslricled donalion of £800,000 from Iwslee Mr C J Wansbrough, plus Gift Aid. This donation was givèn specifically lo support HRI'S research activilles, with the express inslruclion Ihal the capilal be invested and the inveslment in¢om8 used lo fund research. These funds are held within Ihe 'Wansbrough Research. reslricled fund. In ac¢epling this significant donation from a trustee. Ihe charity has underlaken due diligence and sought professional advice to ensure compliance with governance best praclices and regulatory requirements. The Board has reviewed and formally approved the donation in accordance with ils conflicls of interesl policy, ensuring that the process was Iranspaienl. robust, and In Ihe besl inleresls of Ihe charity. Expenditure decreased from £643.480 in 2023 10 £490.511 in 2024, reflecling the absence of cycllcal blennlal conference costs. Key costs remain focused on core staffing, research project dellvery. and research-related communlcalions. The Charity reported a strong unrestricted surplus of £89,783 in 2024. This oulcome reflects light cost control and continued Support from donors. si9nificanlly slrenglhening HRI'S unreslricted reserves position. This result supports Ihe Truslees. slralegic financial objective to bulld and mainlain unrestricted reserves equivalent to 12 months of operalional expenditure by Ihe end of 2025, enabling HRI to remain stable in a challenging funding environment. During the year, the Charily resolved an historical inlercompany balance with 11$ wholly owned subsidiary, Homeopalhy Research Enterprises Ltd, by writing off Ihe outstanding balance (see Note 8). This accounting lieatrnent, approved by the Trustees and based on Professional advice. beller reflects Ihe economic reality of the group slruclure and does not affect Ihe consolidaled posilion. Inves ment oli The charily invests capital funds to generate passive income supporting operational Costs and specific research aclivily, as well as providing a contingency to support Ihe reserwos policy in times of crisis. Investments are managed for the medium to long temi, wilh a focus on generating regular income and modest capital growlh. Investment decisions are made wilh due regard to risk, diversification, liquidity. and ethical nSIderatIOns. The charity avoids investments deemed inconsistent wilh ils values and minimal risk slralegy. Investmenl performance is reviewed quarterly and reported lo the Board of Trustees biannually. with additional reporting should Ihe need arise. Doc10: 23ba9c743a1011a57a3dd7681 ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE TRUSTEES, REPORT (CONTINUED)(INCLUDING DIRECTORS, REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 erves The Truste8s aim to maintain unrestricted reserves equivalenl to 12 rnonlhs of operaling expenditure by lh8 end of 2025. This largel is aligned with Charity Commission (CC) guidance (i.e. Ihe level of reserves should reflecl Ihe particular circumstances and commitmenls of the individual charity - para 3.4: Building resilience) and reflects HRI'S calegorisalion by the CC as a 'large charily, (income > £500k per year}. These reserves provide rinandal slabilily, protects against income volatility. and enables long-lerm planning for oulpul and operation8. The reserves level is reviewed annually lo ensure it remains appropriate for the charily's needs and risk profile. Plans for Ihe future The charity plans to continue the key activities oullined above In forthrA)ming years, subject to satisfaclory funding arrangements. Successful recnjilment in Q4 2023 HRI ol Iwo part-time researchers, enabled us to expand Ihe Institute's academic capacity from January 2024 onwards, conlribuling to our highest level of impact to date towards fulfilrnenl of our Iwo key strategic aims cL>nlributing lo Ihe generation of new high-quality research in homeopathy and promoting accurate cornmunicalion of Ihe evidence base. However. further recrullmenl will be needed in 2025, most urgently a new adminislralive assislant to replace a leam member who sadly passed away in 2024. structurei gov?rnance and management HRI 18 registered as a charity in England and INales. The charity is also a company limited by guarantee, a deed ol Irust. and conslilutes a company limited by guarantee. HRI'S governing Instruments are a Memorandum and Artlcles ofAssociation. The Iruslees. who are also the directors for the purpose of company law, and who sep4ed during Ihe year and up lo the date of signature ol the financial statements were.. Dr A L Tournier Mr C J Wansbrough DrAHARoss MrA F T Winkler t)oc ID.. 23ba9c743a1011a57a3dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE TRUSTEES. REPORT (CONTINUED)(INCLUDING DIRECTORS, REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 None of Ihe truslees has any beneficial interest in the company. All of the trustees are members of the company and guarantee to contribute £1 in Ihe evenl of a winding up. Dr A L Tournier, Trustee, receives lunds in respect of research work carried oul on behalf of the charity and fulfilment of his role as Executive Direclor. Full disdosure of the amounts is given in the notes to the accounts. Recruitment and a ointment of Truslees The power to appoint new Tfuslees rests with the current Trustees and if it Is felt appropriate, they will look for new Tfuslees with relevant skills and experience. New Trustees are appoinled following a successful inlefview with Ihe exisling Tfuslees. Or anisali nal slruclure The Trustees delegate the responsibility of ensuring policies and procedures are carried out and Ihe operational management of Ihe charily to the Chief Executive, Ms Rachel Roberls. She heads up our staff leam, made up of employees and conlradors. who advise on and deliver the work of the charity. ff mana emen HRI is forlunate in having skilled and dedicated people. both as employees and conlraclors. At the close of this rinan¢lal year, the HRI team ¢onsisls of 3 full lim8 employees. 1 part lime employee and 3 conlractors. The pay of all staff is reviewed annually and any increase relaling to cost of Ilving may lake inlo consideralion external factors, such as the economic environment and market rate reviews. as well as Ihe charity's financial po$illon. din HRI has one subsidiary, Homeopalhy Research Enlerprises Llmited, wholly owned and registered in England and Wales. The principal aclivily of Ihis company Is consultancy work, providing expert academic input to projects relating lo scienlific research. These include, bul are not limited to. projects involving communicating outcomes from research sludies and improving Ihe quality of new scientific research studies. Risk mana emen The Trustees have assessed the major risks lo which the charity is exposed and are satisfi8d thal systems are in place to mitigate exposure lo Ihe major risks. The main major risks identified relate to maintaining voluntary income and Ihe performance of our Research Conferences and funded pro11$. Audltor In accordance with Ihe company's articles, a resolulion proposing Ihat Mander Duffill be reappointed as auditor of Ihe company will be put at a General Meelin9. The trustees, report was approved by the Board of Truslees. Dr A L Toumler Trustee Dated.. 2711012025 Doc ID: 23ba9c743a1011a57a3dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE STATEMENT OF TRUSTEES. RESPONSIBILITIES FOR THE YEAR ENDED 31 DECEMBER 2024 The trustees, who are also the directors of Homeopalhy Research Institute for the purpose of company law. are responsible for preparing Ihe Trustees. Report and the financial stalemenls in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the tnjslees to prepare financial slatements for each financial year which oive a true and fair view of Ihe stale of affaifs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for Ihal year. In preparing these financial stalemenls, Ihe trustees are required to.. select suitable accounting policies and then apply them consislenlly: obserye Ihe method5 and principles in Ihe Charilies SORP; make judgements and eslimates Ihal are reasonable and prudent., slate whelher applicable UK Accounling Standards have been followed, subjecl to any material departures dis¢losed and explained in the financial slalem8nls'. and prepare the financial statements on the goin9 cK)ncem basis unless il 1$ Inappropriate to pSuMe Ihal the charity wlll Continue in opefalion. The Irustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any lime the financial position of the charity and enable Ihem to ensure that Ihe financial statements comply with Ihe Companies Act 2006. They are also responsible for safeguarding the assets of Ihe charity and hence for laklng reasonable sleps for the prevention and detection of fraud and other irregularities. Do¢10: 23ba9¢743a101 la57a3dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE INDEPENDENT AUDITOR'S REPORT TO THE TRUSTEES OF HOMEOPATHY RESEARCH INSTITUTE Opinion We have audited the ffinancial statements of Homeopalhy Research Inslilule {Ihe 'charity') for Ihe year ended 31 December 2024 which comprise Ihe slalement of financial activities, the balance sheet, Ihe stalemenl of cash flows and notes to the financial stalements, including significant accounting policies. The financial reporling framework that has been applied in their preparalion is applicable law and United Kingdom Accounting Standards. including Financial Reporting Standard 102 The Fin8ncial Reporting Slandard applicable in Ihe UK and Republic of Ireland (Uniled Kingdom Generally Accepted Accounting Practice). In our opinion, the financial slalemenls: give a true and lair view of the state of the charitable companrfs affalrs as at 31 Decemb8r 2024 and of its Incoming resources and application of resources, lor the year then ended: have been properly prepared in accordance wilh Uniled Kingdom Generally Accepted Accounling Pracllce: and have been prepared in accordance with the requirements of the Companies Act 2006. 8a815 for oplnlon We conducted our audit in accordance with International Standards on Audiling (UK) (ISAS {UK}) and applicable law. Our responsibilities under those standards are further described in Ihe Auditorfs rnsponsibilili8s for Ihe audit of the financial slatemenls section of our report. We are independent of the charily in acLordance with lh8 ethical requirements that are relevant to our audit of the financial statements in Ihe UK. including the FRC'S Ethical Standard, and we have fulfilled our olher elhi¢al responsibilities in accordance wilh Ihese requlremenls, We believe that Iha audit evidence we have oblained is sufficienl and appropriate to provide a basis for our oplnlon. Concluslons relatlng to golng ¢oncern In audiling the finanaal slatemenls. we have cL)ncluded that the truslees. use of the going concem basis of accounling in the preparation of th8 financral slalemenls is appropriale. Based on the work we have perform8d, we have not Idenllfied any material uncertainlles relatlng to events or condilions that. individually or cKJlleclively. may cast significant doubt on the charily's abilily lo continue as a going concern for a period of al least e1ve months fiom when the financlal slalemenls are aulhorised for issue, Our responsibililies and the responslbilttles of the truslees wilh respe io going concem are described in the relevant seclions of this report. other informatlon The olher informatlon comprises the information induded in Ihe annual report other than the financial statements and our audilorfs report thereon. The truslees are responsible lor the olher infomiallon Contained within the annual report. Our opinion on the financial statements does not cover Ihe other information and we do not express any form of assurance conclusion Ihereon. Our responsibility is to read the other infomiation and, in doing so, consider whether the olher information is malerially inconsistent wilh the financial slalements or our knowledge obtained in the course of Ihe audil, or otherwise appears to be materially misstated. If we identify such material inconsistencles 01 apparent material misslatemenls, we are required to determine whether this gives rise to a material mlsstalement in the financial slalemenls Ihemselves. If, based on Ihe work we have performed. we conclude Ihal Ihere is a material misslatetnenl of this other infonrtrallon, we are required to report that facl. We have nolhlng lo report in this iegard. Matters on which we are required to report by exceptlon We have nolhing to reporl in iespecl of Ihe following mallers in relalion to whlth the Charities (Accounts and Reports) Regulations 2008 requires us lo ieport to you if. in our opinion.. Ihe informalion given in Ihe financial statemenls is in¢onsistenl in any material respect with Ihe truste8S' report., or SUffient accounling records have not been kept" or Ihe financial slalements are not in agreement with the accounling records: or we have not received all the informalion and explanations we require for our audit. Doc ID.. 23ba9c743a1011a51a3dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF HOMEOPATHY RESEARCH INSTITUTE Responslbllltles of trustees As explalned more fully in the slalemenl of truslees. responsibililies, Ihe trustees. who are also the directors of the charily for Ihe purpose of company law, are responsible foi Ihe preparation of the financial statemenls and for being $alisfied that they give a Ifue and fair view, and for such inlernal control as the Irustees delennine is necessary to enable Ihe preparation of financial statements that are free Ifom material misslalemenl. whelher due to fraud or error. In preparing Ihe financial slalements, the truslees are responsib18 for assessing the charity's ability lo continue as a going concern. disclosing. as applicable, matlers related to going ¢on¢em and using the going concein basis of accounting unless the trustees either tnlend to liquidate Ihe charitable company or lo cease operations, or have no realislic alternaliv8 but to do so. Audltorfs responslblli1188 for the audlt of the financlal $tstom¢nts We have been appoinled as auditor under seclion 144 of Ihe Charities Act 2011 and report in accordance wilh the Act and relevant regulalions made or having effect Ih8reunder. Our objeclives are lo obtain reasonable assurance about whelher the financial slatemenls as a whole are free fiom maleiial misslalement, whelher duè lo fraud or erfol. and to issue an audilofs report Ihal includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee Ihat an audit conducted in accordance with ISAS (UK) will always delect a material misslalemenl when il exists. Misslatemenls can arise from fraud or error and are considered material if. individually or in Ihe aggregate, they Uld reasonably b8 expecled lo intluence the economic decisions of users taken on the basis of Ihese financial slalements. The extent lo which our procedure5 are capable of detecting iTregulartties. includlng fraud, is delailed b810w. In planning and designing our audil tests, we identify and assess the risks of malerial mis-statements, whether due to fraud OT error. Our risk assessment procedures includ8d- Enquiries of management aboul the entities policies and procedures on compliance wilh laws and regulations and whether Ihey were aware of any instances of noncompliance together wilh the Internal conlrols established to miligale risks of fraud or non-cK)mplian¢e with laws and regulations. Enquiri8s of management about Ihe entilies policies and pioceduies on fraud risks. Includlng any aclual, suspected or alleged fraud. Considered the nalure of the industry and sector, control environment and business performance Includlng the key drivers for directors, remuneration, bonus levels and performance targets. Reading minutes of meetings of those charged with govemance. We communicated relevant identified laws and regulalions and potential fraud risks lo all engagement leam members and remained alert to any Indications of fiaud or non-compliance wjlh laws and regulations throughout the audit. We oblained an underslanding of the legal and regulatory frameworks Ihal Ihe entity operates in, Ihrough discusslons with the director, and from our commercial knowledge and experience ol the sector in which the company operates, to enable us lo idenlify Ihe key laws and regulations applicable lo the company. We focused on specific laws and regulalions which we ¢ongidered may have a direct material effect on the finandal slalemenl 01 the operations of the company, including Ihe Companies Act 2006. laxalion legislalion, data proleclion, anli.biibery, employment, environmental and heallh and safely legislation. Doc ID: 23bagc743a1011a57a3dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF HOMEOPATHY RESEARCH INSTITUTE As a result of these prodreS. we considered the opportunilies and incenlives Ihat may exisl wilhin the organisalion foi fraud. In common with all audils under ISAS (UK). we are also requifed to P8rfoim specific procedures lo respond lo Ihe risk of management override of conlTols including the following.. Reviewing financial stalemenl disclosures and testing lo supporting documentation lo assess compliance wilh applicable laws and regulalions. Enquiry of managem8nt concerning actual and potential liligalion and claims. Reviewing correspondence wilh HMRC, and Ihe company's legal advisors. Addressing ihe risk of ffaud through managemenl override of controls, testing the appropriateness of journal entries and other adjuslmenls. assessing whether judgements made in making accounling estimates are indicative of a potential bias. and evalualing the business ralionale ol any signtficanl transactions Ihal are unusual or outside the normal course of business. Owing lo Ihe inherent limilalions of an audit. Ihere 15 an unavoidab18 risk Ihal we may not have d&lècted som8 material misslatemenls in Iha financial statements, even though we have properly planned and performed our audit in accoTdance wllh audiling standards. The more removed Ihal laws and regulations are from finanrial transactions, the less likely11 1$ that we would become aware of non-compliance. In addition. as with any audit, Ihere remained a high8r risk of non-deleclion of fraud. as these may Involve collusion. forgery, intentional omissions. misrepresentations, (x the override of internal conliols. Our audit procedures are designed to delect material misstatemenl. We are nol responsible for preventing non.compliance or fraud and cannol be expected to detecl non-compliance wilh all laws and regulations. A furih8r description of our responsibilities is available on Ihe Financial Reporting Council's website at.. hllps'.11 Yrnw.frc.org.uklauditOTsr8sponsibilities. This desuiplion forms part ol our audilorfs report. U80 of our report This report Is made solely to the charity's Irus188s, as a body. in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might slate lo Ihe charity's tfuslees Ihose matters we are required to slate lo them in an audilor's report and for no other purpose. To Ihe fullest exlenl permitted by law, we do not accept or assume responsibility lo anyone other Ihan the charily and Ihe charity's Irustees as a body. for our audit work, for this report, or for the opinions we have formed. Mander Duffill Chartered Ac¢ounlanls & Stalulory Auditor The Old Posl Office 41-43 Market Place Chippenham Willshire SN15 3HR Dale.. Mander Duffill is eligible for appointment as auditor of Ihe Charity by virtue of ils eligibilily for appolntment as auditor of a company under seclion 1212 of Ihe Companies Act 2006. tYo¢ ID". 23ba9c743a1011 a57a3dd7681a¢7b3bca9827¢aa
HOMEOPATHY RESEARCH INSTITUTE STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 DECEMBER 2024 Unrestrlcted Restrlcted funds fund$ 2024 2024 Total Total 2024 2023 Notes Incom• from: Donalions and legacies Charitable aclivilies Inveslmenls 559,213 1,022.932 1,582,145 7.294 7.294 23.426 577,882 134,989 23.428 Total income 566.507 1.046.358 1,612.B65 712,871 Ex endlture on: Raising funds 6,722 8,722 8,324 Charitable activilies 468.220 15,569 483,789 635,156 Total re80ur¢e8 expended 474,942 15.569 490,511 643,480 Net Income for the yearl Net Incomlng resources 91.585 1.030,789 1.122,354 69.391 other re¢ognl8ed galns and1038e8 Other oains or losses 13 (1,782) (1,782) {1,767) Net movement in fund8 89.783 1.030,789 1,120,572 67,624 Fund balances al 1 January 2024 426,213 66,104 492.317 424,693 Fund balances at 31 December 2024 515.998 1.096,893 1.612,889 492,317 The slatemenl of financial aclivilies includes all gains and losses re(x>gnised in Ihe year. The statement of financial activilies indudes all gains and losses r8cognised in Ihe year. All income and expenditure derive from continuing activities. The statement of financial adivilies also complies with the requirements for an income and expendilure account under Ihe Companies Acl 2006. 10- Doc ID: 23ba9c743a101 la57a3dd7681ac7b3b¢a9827caa
HOMEOPATHY RESEARCH INSTITUTE BALANCE SHEET AS AT 31 DECEMBER 2024 2024 2023 Notes Flxed assets Tanglble assels Investments 14 15 816 100 1,827 100 918 1,927 Current assets Debtors Cash at bank and in hand 16 29.702 1.644,720 57,125 449,612 1.674.422 506.737 Credltor8: amounts falllng duo within one year 17 (62,449) (16,34n Nel current assets 1.611,973 490.390 Total a88ets less current Ilabllllle8 1.612,889 492,317 Income funds Restricted funds Unrestricted funds 18 1.096,893 515.9 66,104 426.213 1.612.889 492.317 These financial statemen1$ have been prepad in accordance with Ihe provisions applicable to companles 8ubjecl lo the small companies regime. 271TOI2025 The accounts were approved by the Trustees on ......................... Di A L Tournier TTUStee Company Reglstratlon No. 06230101 11 Doc ID: 23ba9c743a1011a57a3dd76818¢7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2024 2024 2023 Notes Cash flows from operating a¢tlvltles Cash generated from operations 1,171,682 101,364 Invesllng a¢llvltles Purchase of tangible fixed assets Interest received (2.415) 23.426 Not ¢a8h generated froml(used In) invgstlng actlvltlgs 23,426 (2,415) Net ca$h used In flnanclng actlvltles N6t increase In cash and ca8h equlvalents 1.195,108 98,949 Cash and cash equivalenls at beginning of year 449,612 350,663 Cash and cash equlvalents at end of year 1,644,720 449.612 12- Doc ID: 23ba9c743a1011a57a3dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Accountlng policies Charity Informatlon Homeopathy Research Inslitute is a private company limited by guafantee incorporaled in England and Wales. The registered office is Inlernalional House. 142 Cromwell Road, Kensington, London. sihri 4EF. 1.1 Ac¢ountlng conventlon The accounts have been prepared in accordance with Ihe d)arity'S governing docum8nt. the Companies Acl 2006 and 'Accounling and Reporting by Charities: Slatemenl of Recommended Practice applicable to charilies preparing their accounts in aCrdance with the Financial Reporting Standard applicable in the UK and Republic ol Ireland (FRS 102). (as amend8d for accounling periods commencing from 1 January 2016). The charity is a Public Benefit Enllty as defined by FRS 102. The financial slatemenls are prepared in stefling. which is the funclional currency of the charlly. Monetary amounts in these financial statements are rounded to Ihe nearest £. The financlal statements have been prepared under the historical cost Convention. The princip81 accounting policies adopted are sel out below. 1.2 Golng concern At Ihe lime of approving the financial stalemenls, the Iruslees have a reasonable expeclalion Ihat Ihe charity has adequate resources lo conlinue in operational èxistence for lh8 foreseeable future. Thus the Iruslees conlinue to adopt the going concern basis of accounting in preparing the financial slalemenls. 1.3 Charltablo funds Unrestricted funds are available for use at th8 discretion of the trustees in furtherancè of thelr charllable objectives. Designated funds are unrestricted funds of the charily which the Trustees have decided at their discr81ion to set aside to use for a Specif purpose. The purposes and uses of the designated funds ara sel out in the notes to th8 accounts. Reslricled funds are subject to specific conditions by donors or grantors as to how Ih8y may be used. The purposes and uses of Ihe festricled funds are set out in Ihe noles to Ihe financial slatemenls. 1.4 Incomlng resourcei All income is recognised when the charity has enlillement to the funds. it is probable that Ihe Income will be reiVed and Ihe amount Can be measured ieliably. 1.5 Rosour¢e8 expended Expendilure is recognis8d as soon as a liability is probable. 13- Doc10: 23ba9c743a1011a57a3dd7681a¢7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Ac¢ountlng pollcles (Contlnued) ExpenditUTe is dassified under Ihe following aclivity headings: Cosls of raislng funds. being the promotion of the work of the Charity Expenditure on charitable aclivilies, being mainty project fvnding and management Other expenditure, being amounls not falling into the above headings Allocation of support costs: Support costs are those functions thal assisl the work of the charily but do not directly urKlertake charitable aclivilies. These costs have been included under the heading of charitable aclivilies. 1.6 Tanglble flxed assets Tangible fixed assets are inilially measured al cost and subsequenlly measured at cost or valuation, net of depreciation and any impaimient losses. Depreclalion is recognised so as lo write off Ihe cost or vatuation of assets less their residual values over Ihelr useful Iiv8s on the following bases.. Computers 33% on $t The galn or loss arising on the disposal of an asset is determined as Ihe difference between Ihe sale proceeds and Ihe carrying value of the asset, and is recognised in the slatement of finanual activities, 1.7 Flxed asset Inv6Stments A subsidiary is an enlity controlled by Iha charity. Conlrol Is the power to govern Ihe financial and operating policies of Ihe enlily so as lo obtain benefits from ils activities. Inveslments in subsidiary undertakings are shown at cost. 1.8 Impaimient of flxed assets At each reporting end dale, Ihe charity reviews Ihe carrying amounts of Ils tangible assets to delemiine whelher there is any indication Ihal those assels have suffered an impairmenl loss. If any such indicalion exists, the recoverable amounl of the asset is estimated in order lo determine Ihe exient of Ihe impairment loss (if any). 1.9 Cash and cash equlvalents Cash and cash equivalenls include cash and short-term highly liquid inveslments wilh a short maturity of Ihree months or less, and bank overdrafts. Bank overdrafts a shown wilhin borrowings in current liabililies. 1.10 Financlal Instruments The Irust only has financial assets and financial liabiliiies of a kind that qualify as basic finanaal instruments. Basic financial instiumenls are inilially rècognised al transaclion value and subsequently measured at Iheir settlement value. 1.11 Employee beneflts The cosl of any unused holiday enlillement is recognised in the period in which Ihe employeè's setvices are received. 14- Doc ID: 23ba9c743a101 la57a3dd7681 ac7b3b¢a9827¢aa
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 A¢countlng policleg Icontinued) 1.12 R8tlrement benefits Payments to defined contribulion retirement benefit schemes are ¢harg8d as an expense as they fall dua. 1,13 Forelgn exchange Transactions in currencies other than pounds slerling are recorded al the rates of exchang6 prevailing al the dales of the transactions. Al each reporting end dale, monelary assels and liabilities that are denominated in foreign curfencies are relranslaled al the rates prevailing on the reporting end dale. Gains and losses arislng on Iranslalion are Included in nel incomel{expendilure) for the peflod. 1.14 Ba¥ls of Preparatlon- Group Accounts The charily has a subsidiary underlaking bul has not prepared consolidated financial stalemenls for the year ended 31 December 2024. This is in accordance with lh8 exemption available under Section 399(2) of the CompaniesAcl 2006, on the grounds that the subsidiary is immaterial. The resulls of the subsidiary are not material lo Ihe charily's financial stalemenls. and ils exciuslon does not 8ffe¢l the true and fair view of the financial stalemenls. Donatlon8 and legacles Unrostrlcled Re8trlcted funds fund8 Total Tolal 2024 2024 2024 2023 Donations and gifts 559,213 1.022,932 1,582,145 577,882 Charltable activllles Unrostrlcted fund$ 2024 Total 2023 Conference income Other income 122,910 12.079 7,294 7,294 134,989 15- Doc ID: 23ba9c743a1011a57a3dd7681a¢7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Income from investments Restrl¢ted fund5 2024 Restrlcted funds 2023 Interest receivable 23.426 Raising funds Unrestrlcted funds Total Total 2024 2024 2023 Fundraising Other fundraislng costs Staff costs 2,996 3,726 2,996 3.726 5,779 2,545 Fundraising 6,722 6.722 8,324 16- Doc ID: 23ba9¢743a101 la57a3dd7681 ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Chirltibl• •¢tlYltl R•1•1 r¢•¥••r¢h liellllallon & dlBs•mlnallon Oth•r Tot•1 2024 Tolol 2023 m•o4g•rn•nl & d•v•lopm•nl siaff <018 HRI Cw Te8m thwN8rrt Exlornal contraclori R•seari fvndlng & ivpw1 HRI ClrentS & Ext•fft Ev¢rn• Tra¥il & Sub¥hlen¢• Po$1. leph•, %la1knory & sundrfe• Armjnlancy Srs¥u¥dncè Sofvwt & IT L•oal ond wo1•88kJnAlle•i Oowecialh)n Ronl alx1 l•¥ Lo•nw4h¥t¢ wb65YIgry 15.122 26.383 12.695 13.260 140,358 29.104 03.891 3,977 2,488 243.318 66,51? 12.695 13,515 6,49) 5,141 3.247 26.989 1.487 7.730 12.880 1.011 17,973 52,784 244,570 34,08 975 113.187 137,795 265 6.131 4S 24 193 10,128 15,462 2,078 16,016 15,7eo 26,989 1.487 4.397 4.825 3,892 1.011 17,973 18,877 52,784 72,334 183.652 152,789 83.014 471,789 635,IS6 Audil l¢• I2,) 12.Cfj) 183.652 152.789 75.014 493.789 63S,188 17. ID.. 23¥th74l0lI•S7•3&d7681•¢7ty9a2Ttl
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Grants payable 2024 2023 Donation to Universily of Bristol for otitis media syslemattc review Conlribulions to Cartwright Physico•Chemical Investigalion Conlribulion to Bern Basophil Proje¢l Donation to Universily of Technology Sydney lor su0Y project Grants for allending HRI London Conference Small grants supporting Iwo research projects 21,860 28.000 50,000 8,225 5,302 12.000 1,515 Totsl 13,515 113,187 Loan waiver to Subsldlary In 2024. the Charity formally resolved an hislorical inlercompany balanc8 wilh its wholly owned subsidiary, Homeopathy Research Enterprises Ltd (HRE). by wriling off the outstanding amount. This action followed professional accounling advice and a comprehensive internal review of the subsldiary's financial position. The decision was approved by the Board of Truslees al ils meeting on 24 Octobèr 2024 and reflects the practical realities of the group slruclure and Ihe current role of HRE in supporting the Charity's broader mission. As the organisalion felains full control of HRE. Ihe wrile-off is accounled for as a loan waiver lo Ils subsidiary and does not impact Ihe consolidaled financial position of the organisalion. This Ireatmenl ensures the balance she81 more accur31ely reflects Ihe economic substance of the relalionshlp between the Charity and ils subsidiary. The Truslees consider Ihis an appropriate slep in Ilne wilh good financial governance and Iransparency. 18- Doc ID: 23ba9c743a101 la57a3dd7681a¢7b3bca9827¢aa
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Net movement In funds 2024 2023 The net movement in funds is slated after chaigingl{crediting)- Fe8s payable to the charills audilor.. for the audit of the charity's financial statements for oth6r financial services Deprecialion of owned langible fixed assets 12,000 852 1.306 1,011 10 Trusteeg No amounts were ieimbursed lo truslees for expenses Sncurred in acllng in thal capacily.(2023'. Expenses of £1.225 were reimbursed lo two Iwstees for expenses incurred in acting in Ihal capacity). Dr A L Tournier, Trustee. was paid consultancy fees and expenses of £15.724 (2023.. £18,061). This is In respecl of work carrled oul on behalf of the Charity. The iemuneralion was paid In accordan with the provisions of the governing document ol Ihe Charity. 11 Employees The average monthly number ol employees during Ihe year was: 2024 Number 2023 Number Employment costs 2024 2023 Wages and salarles Social security costs Other pension cosls 222,230 21,179 3.665 222,550 20.692 3.873 247,074 247,115 The number of employees whose annual remuneration was more than £60.000 is as follows= 2024 Numbor 2023 Numb8r £80.000 to £90.000 £90,000 to £100,000 19- Doc ID.. 23ba9G743a1011a57a3dd7681ac7b3b¢a9827caa
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 11 Employees Icontlnued) Remuneration of key management personnel The remuneration of key managemenl personnel was as follow5.. 2024 2023 Total employment benefits, including employer pension ¢onlribulions and employer National Insurance contributions 103,938 99,202 12 Taxatlon The charity is exempl from laxallon on its acllvlties because all ils Income is applied for charitable purposes. 13 Other galns or loss•s Unr•strict•d funds Total 2024 2023 Foreign exchange lossesl(gains) 1,782 1,767 14 Tanglble fixed assets Comput•M C08t At 1 J8nuary 2024 6,360 At 31 December 2024 6,360 Depreclatlon and impaim)ent At 1 January 2024 Depreciation charged in Ihe year 4.533 1.011 At 31 December 2024 5.544 Carrylng amount At 31 Dernb8r 2024 816 At 31 December 2023 1,827 -20- Doc ID". 23ba9c743a1011a57a3dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 15 Foxed asset Investment8 Other investments Cost or valuatlon Al 1 January 2024 & 31 December 2024 100 Carrylng amount At 31 December 2024 100 Al 31 December 2023 100 2024 2023 Other investments comprise". Note8 Investments in Subsidiaries 23 100 100 16 Debtors 2024 2023 Amounts falllng due wlthln one year: Trade debtors Amounts owed by subsidiary undertakings Other debtors 4,147 53,458 3,667 25,555 29,702 57,125 17 Crèdltors: amounls falllng due withln one year 2024 2023 Olher laxalion and social security Trade credilors Amounts owed lo subsldiary undertakings Olher creditors 10.463 9,945 783 41.258 9,446 3.531 3.370 62.449 16,347 -21 Doc ID.. 23ba9c743a1011a57a3dd7681ac7b3b¢a9827caa
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 18 Restrlctsd funds The restricted funds of Ihe charity comprise the unexpended balances of donations and grants held on twst subject to specific conditions by donois as to how Ihey may be used. Movement Sn funds Incomlng Resources Balance at 31 resources expended December 2024 Balancè at 1 January 2024 Cartwright Physico-chemical Investlgations Malhie Plus SRS MHC Clinical Research MHC Educational Grant Scheme Mosley Arnica Review Olilis Media Systematic Review UK TCIM Survey Wansbrough Research Fund 2,000 12,989 35.455 8.611 4.245 2,804 10,000 4,277 (12,000) {2,720) 14,546 35,455 8,611 3,805 2,804 8,246 1,023,426 (440) 8,655 1,023,426 (409) 66,104 1.046.358 (15,569) 1,096,893 -22- Doc ID.. 23ba9c743a101 la57a3dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 18 Restrlcled funds Icontlnued) The reslflcted funds are as set out below: Cartwrlght Physlco-chemlcal Investlgatlons HRI provides financial supporl to an ongoing fundamental science projecl 6xploring the possible mechanism of aclion of homeopathic medicines by Dr Steven Cartwrighl i.e. using solvalochromic dyes to Investigate the physico-chemical properties of homeopathic dilulions. Mathle Plu8 SRS There is a recognised need for more systematic reviews (SRS) on homeopathy, to clarify th8 slatus of Ihe existing evidence and lo inform fuluTe research. Thls fund - named in reference lo the seminal work In this field by Dr Robert Mathie - received funds in 2024 towards new research planned for 2025. MHC Cllnlcal Research These funds, provided by Manchester Homeopathic Clinic, have been provided to Support clinical research In homeopathy. As per the donor's dir8dions. the funds will be allocaled to suitable projecl(s) chosen by HRI. There have been no financial movemenls on Ihis fund in 2024. MHC Educatlonal Grant Scheme A donation of £20k from Manchesler Homeopathlc Cllntc is used lo support educalit)n of homeopalhs In homeopathic research via a series of 'HRI Educational Grant, schemes. In accordanc8 with Ihe wishes of Ihe donor, this funding is made available to UK residenls via periodic grant Galls, and has supported successful appli¢anls in attending the bienni81 HRI Conferences since 2017. Mosley Arnlca Rovlew HRI Is acting as fund-holder and adminislrator for Ihls project conducling a sy$tematSc review of the evidence for the homeopathic medicine Afnica montana. Th1$ project has been on hold since Q4 2021, In 2024, followlng discussion with lead author Dr Mosley. HRI funds previously provided lo this projecl have been returned. such that the Institule now only holds external funds for this proj8d which aims to restart Sn 2025. Otitls Medla Sy8temallc Revlew These funds support closely associaled projects. A syslemalic revlew of homeopathy in Ihe Irealmenl of acute olilis media, led by Dr Esther van der Werf in collaboration wilh the Univeisily of Bristol, as well as Dr Teut at Charilé University, 8erfin, was compleled in 2024. The findings from this sludy dernonstrated a clear need for a Core Outcome Set for Olilis Media. leading to continuation ol Ihis academic collaboration in the form of HRI'S new 'COS.OM' project for 2024-2025. -23- Doc ID: 23ba9c743a1011a5783dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 18 Restrtcied funds (Continued) UK TCIM Survay This reslficled grant funding Irom The Blackie Foundation Tw5t of £7,905 wlll co-fund a scientific survey to clarify the status of Tradilianal Complementary and Integrative Medicines ITCIM) in the UK, with a specific focus on homeopathy. This projecl is being conducted in collaboration with ARCCIM at Universily of Technology Sydney, Australia. Wan8brough Research Fund These funds, provided by Mr Charles Wansbrough, are reylricted to Ihe support of homeopathy research projects. In accordance wilh the donor's instruclions, the capilal is to ba invasled. and any income generated restricted lo this same purpose. These combined funds are available for allocation to suitable projects{s) chosen by HRI, which are aligned wilh the Institute's charitable aims. 19 Unrestrlcted fund8 At 1 January 2024 Incomlng Rp8our¢e8 resource• expended Transferd Galns and losses At31 December 2024 General funds 426.213 566.507 (474,942) (1.782) 515,996 Pr6vIou8 yoar: At 1 January 2023 Incomlng Resources re8ourc8s expended Transfer8 Galn8 and losse8 At31 December 2023 General funds 372,701 560,603 (505,350) 26 (1,767) 426,213 20 Analysls of net a88ets betwe•n fund8 Unrostrlctod R•gtri¢ted 2024 2024 Total 2024 Total 2023 Fund balances at 310ecember 2024 are represented by: Tangible assets Inveslmenls Current asselsllliabililies) 818 100 515.080 816 100 1,811,973 1,827 100 490.390 1.096,893 515,996 1.096,893 1,612,889 492.317 -24- Doc ID: 23ba9¢743a1011a57a3dd7681 ac7b3bca9827ca8
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 21 Operatlng lea8e Commllments Lessee At Ihe reporting end date the charily had outstanding cx)mmitments for fuluie minimum lease paymenls under non-cancellable operating leases, which f811 due as lollows= At the reporting end dale the charily had outstanding cornmitments for fuluie minimum lease paymenls under non-cancellable operating leases, which fall due as follows= 2024 2023 Within one year 2,116 2,058 22 Related party tran8action8 Tran8actlon$ wlth related partl Payments lo Trustees: During the year Ihe charity mad8 payments to Trustees as disclosed above. Donation Irom Trustee.. During Ihe year, Ihe charity received a restricted donation of £800.000 from tnjstee Mr C J Wansbmugh, plus associaled Gift Aid of £200,000, tolalling £1.000.000. The funds are induded in the reslricled fund "Wansbrough Research Fund" (see Note 17). In line with Ihe donor's inslruclions, the capital is lo be invested, and only Ihe Income generaled used to fund research aclivilies. The donation is reslricled both in use and form. The Board undertook appropriate due diligence and sought professional advice before accepiing Ihe gift, and formally approved it in accordance wilh Ihe charily's Conflicts ol Interest Policy. -25- Doc ID.. 23ba9c743a101 la57a3dd7681ac7b3bca9827caa
HOMEOPATHY RESEARCH INSTITUTE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 23 Subsidiaries These financial stalements are separate charity financial stalemenls for Hom80palhy Research Inslilule Limited. Details of the charitys subsidiaries al 31 December 2024 S as follows: Name of undertaklng Registered offlce Nature of buslne88 Cla88 of % Held 8hare8 held Dlrect Indlroct Homeopathy Research Enterprises Ltd UK Provtslon of infomation on Homeopathy Research Enterprises Ltd Ordinary shares 100.00 The aggregale capilal and reserves and the result for the year of subsidlaries excluded from consolidalion was as follows: Name of undertaklng ProflV(Lo88) Capltal and Re8eNes Homeopathy Research Enlerprises Ltd 53,234 6,325 Do¢ ID: 23ba9¢743a101 la57a3dd7681ac7b3bca9827caa